95 related articles for article (PubMed ID: 18043718)
21. The adult neural stem and progenitor cell niche is altered in amyotrophic lateral sclerosis mouse brain.
Liu Z; Martin LJ
J Comp Neurol; 2006 Jul; 497(3):468-88. PubMed ID: 16736475
[TBL] [Abstract][Full Text] [Related]
22. Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation.
Witan H; Kern A; Koziollek-Drechsler I; Wade R; Behl C; Clement AM
Hum Mol Genet; 2008 May; 17(10):1373-85. PubMed ID: 18211954
[TBL] [Abstract][Full Text] [Related]
23. Determinants of rapid disease progression in ALS.
Yamanaka K; Cleveland DW
Neurology; 2005 Dec; 65(12):1859-60. PubMed ID: 16380607
[No Abstract] [Full Text] [Related]
24. Familial amyotrophic lateral sclerosis and Alzheimer's disease. Transgenic models.
Wong PC; Borchelt DR; Lee MK; Pardo CA; Thinakaran G; Martin LJ; Sisodia SS; Price DL
Adv Exp Med Biol; 1998; 446():145-59. PubMed ID: 10079842
[No Abstract] [Full Text] [Related]
25. RNA interference protects against ALS in mouse model.
Burton A
Lancet Neurol; 2005 May; 4(5):274-5. PubMed ID: 15861555
[No Abstract] [Full Text] [Related]
26. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.
Jonsson PA; Graffmo KS; Andersen PM; Brännström T; Lindberg M; Oliveberg M; Marklund SL
Brain; 2006 Feb; 129(Pt 2):451-64. PubMed ID: 16330499
[TBL] [Abstract][Full Text] [Related]
27. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
Watanabe S; Nagano S; Duce J; Kiaei M; Li QX; Tucker SM; Tiwari A; Brown RH; Beal MF; Hayward LJ; Culotta VC; Yoshihara S; Sakoda S; Bush AI
Free Radic Biol Med; 2007 May; 42(10):1534-42. PubMed ID: 17448900
[TBL] [Abstract][Full Text] [Related]
28. Damaging secretions: chromogranins team up with mutant SOD1.
Sendtner M
Nat Neurosci; 2006 Jan; 9(1):12-4. PubMed ID: 16378088
[No Abstract] [Full Text] [Related]
29. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions.
Kunst CB; Mezey E; Brownstein MJ; Patterson D
Nat Genet; 1997 Jan; 15(1):91-4. PubMed ID: 8988176
[TBL] [Abstract][Full Text] [Related]
30. Mouse model found for ALS.
Marx J
Science; 1994 Jun; 264(5166):1663-4. PubMed ID: 8209242
[No Abstract] [Full Text] [Related]
31. Of mice, men and motor neurons.
Newbery HJ; Abbott CM
Trends Genet; 2001 Oct; 17(10):S2-6. PubMed ID: 11585669
[TBL] [Abstract][Full Text] [Related]
32. SOD1 A4V familial ALS in North America: can understanding the past lead to a better future?
Armon C
Neurology; 2009 May; 72(19):1628-9. PubMed ID: 19176894
[No Abstract] [Full Text] [Related]
33. Copper-zinc superoxide dismutase and ALS.
Valentine JS; Hart PJ; Gralla EB
Adv Exp Med Biol; 1999; 448():193-203. PubMed ID: 10079827
[No Abstract] [Full Text] [Related]
34. What zebras and mice can teach us about familial ALS.
Benatar M
Neuromuscul Disord; 2007 Oct; 17(9-10):671-2. PubMed ID: 17627821
[No Abstract] [Full Text] [Related]
35. Superoxide dismutase and ALS.
Orrell RW; deBelleroche JS
Lancet; 1994 Dec; 344(8938):1651-2. PubMed ID: 7996955
[No Abstract] [Full Text] [Related]
36. RNAi therapy: dominant disease gene gets silenced.
Xu Z; Xia XG
Gene Ther; 2005 Aug; 12(15):1159-60. PubMed ID: 15858609
[No Abstract] [Full Text] [Related]
37. Redox modifier genes and pathways in amyotrophic lateral sclerosis.
Carter BJ; Anklesaria P; Choi S; Engelhardt JF
Antioxid Redox Signal; 2009 Jul; 11(7):1569-86. PubMed ID: 19187001
[TBL] [Abstract][Full Text] [Related]
38. Amyotrophic lateral sclerosis and gene therapy.
Miller TM; Smith RA; Cleveland DW
Nat Clin Pract Neurol; 2006 Sep; 2(9):462-3. PubMed ID: 16932606
[No Abstract] [Full Text] [Related]
39. Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives.
Beleza-Meireles A; Al-Chalabi A
Amyotroph Lateral Scler; 2009 Feb; 10(1):1-14. PubMed ID: 19110986
[TBL] [Abstract][Full Text] [Related]
40. Distribution of MnSOD polymorphisms in sporadic ALS patients.
Tomblyn M; Kasarskis EJ; Xu Y; St Clair DK
J Mol Neurosci; 1998 Feb; 10(1):65-6. PubMed ID: 9589371
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
